* Dolby Laboratories Inc DLB.N DLB is expected to show a
rise
in quarterly revenue when it reports results on May 4.
* The San Francisco California-based company is expected to
report a 4.6% increase in revenue to $349.843 million from
$334.37 million a year ago, according to the mean estimate from
4 analysts, based on Refinitiv data. The company's guidance on
February 2 2023, for the period ended March 31, was for revenue
between $340.00 million and $370.00 million.
* Refinitiv's mean analyst estimate for Dolby Laboratories
Inc is
for earnings of 98 cents per share. The company's EPS guidance
on February 2 2023, for the period ended March 31, was between
$0.90 and $1.05
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Dolby
Laboratories Inc is $90, above its last closing price
of $82.48.
The company's guidance on February 2 2023 for the period ended
March 31 was for gross profit margin of USD89%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.78 0.79 1.11 Beat 41.4
Sep. 30 2022 0.51 0.60 0.54 Missed -10
Jun. 30 2022 0.59 0.59 0.68 Beat 16.2
Mar. 31 2022 0.82 0.82 0.92 Beat 12.7
Dec. 1.06 1.06 1.01 Missed -4.9
31 2021
Sep. 30 2021 0.56 0.56 0.58 Beat 3.1
Jun. 30 2021 0.48 0.48 0.71 Beat 49.5
Mar. 31 2021 0.67 0.67 0.91 Beat 36.5
This summary was machine generated May 3 at 02:08 GMT. All
figures in US dollars unless otherwise stated